VSTM
Verastem IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$360.28M
P/E Ratio
—
EPS
$-2.52
Beta
0.27
52W High
$11.25
52W Low
$3.55
50-Day MA
$5.02
200-Day MA
$7.14
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
-1.89
About Verastem Inc
Verastem, Inc., a developing-stage biopharmaceutical company focused on developing and commercializing life-enhancing drugs for cancer patients. The company is headquartered in Needham, Massachusetts.
Fundamentals
| Revenue (TTM) | $49.59M |
| Gross Profit (TTM) | $42.21M |
| EBITDA | $-169.86M |
| Operating Margin | -240.50% |
| Return on Equity | -786.00% |
| Return on Assets | -59.40% |
| Revenue/Share (TTM) | $0.62 |
| Book Value | $0.74 |
| Price-to-Book | 4.23 |
| Price-to-Sales (TTM) | 7.27 |
| EV/Revenue | 5.04 |
| EV/EBITDA | -0.19 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -78.60% |
| Shares Outstanding | $87.87M |
| Float | $70.40M |
| % Insiders | 0.95% |
| % Institutions | 93.57% |
Historical Volatility
HV 10-Day
81.76%
HV 20-Day
67.50%
HV 30-Day
75.53%
HV 60-Day
73.80%
HV Rank
55.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($16.00 target)
1
Strong Buy8
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026